CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Conditions
- Pancreatic Ductal Adenocarcinoma
Interventions
- DRUG: 64Cu-DOTA-ECLIi
- DEVICE: PET/CT
Sponsor
Washington University School of Medicine
Collaborators